Lonza IPF airway cells

Lonza now offers cryopreserved lung fibroblasts isolated from donors diagnosed with idiopathic pulmonary fibrosis (IPF) for use in research into this potentially fatal condition. Normal lung fibroblasts and small airway epithelial cells — from both smokers and non-smokers — are also available, offering a complete solution to facilitate IPF and other airway research.

Research into IPF is a rapidly growing field; however, a considerable amount of research is still needed if a cure is to be found, as the pathways of disease progression are not yet understood. Furthermore, IPF tissue has until now been difficult for researchers to source.

By providing IPF cells, Lonza makes it convenient for users to quickly progress with their research. The company’s ability to provide primary cells, coupled with detailed donor information, enables researchers to relate donor characteristics to disease progression.

The IPF cells are available together with normal lung fibroblast cells and culture media, providing a complete cell culture solution for IPF research. In addition, the company has the capability to provide custom isolations where required.